...
首页> 外文期刊>American Journal of Hypertension >The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension
【24h】

The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension

机译:氨氯地平和S(-)-氨氯地平对高血压患者血管内皮功能的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background Amlodipine has been shown to improve vascular endothelial function in hypertensive patients, but whether S(-)-amlodipine has a similar effect remains controversial. This study compared the effects of amlodipine and S(-)-amlodipine on vascular endothelial function in hypertensive patients and investigated relevant mechanisms of action in cell culture. methods Twenty-four patients with essential hypertension received amlodipine and S(-)-amlodipine for 6 weeks in a randomized, crossover study. Associated flow-mediated dilation (FMD), nitric oxide (NO), and endothelial nitric oxide synthase (eNOS) levels were determined. NO levels were measured after exposure of human umbilical vein endothelial cells (HUVECs) to amlodipine, S(-)-amlodipine, the eNOS inhibitor N w-nitro-L-arginine (L-NA), and the Protein Kinase C (PKC) inhibitor Ro 31-8220. Phosphorylation levels of Ser1177 and Thr495 in eNOS were determined after exposure to amlodipine, S(-)-amlodipine, and Ro 31-8220. results FMD, NO, and eNOS levels significantly improved after treatment with amlodipine and S(-)-amlodipine. The levels were all higher with amlodipine, although the between-treatment difference was not statistically significant. Amlodipine and S(-)-amlodipine significantly increased NO levels in cultured HUVECs, but increases in NO levels were more marked with amlodipine. Western blot assay showed that both amlodipine and Ro31-8220 induced Ser1177 phosphorylation and weakened Thr495 phosphorylation in eNOS. S(-)-amlodipine had no similar effects. Amlodipine, but not S(-)-amlodipine, decreased the PKC phosphorylation in a time-dependent manner. conclusions Amlodipine and S(-)-amlodipine can both improve endothelial function in hypertensive patients. Amlodipine has greater potential for vascular endothelial protection than S(-)-amlodipine. It affects eNOS phosphorylation at Ser 1177 and Thr495 by the PKC pathway, further enhancing eNOS activation.
机译:背景氨氯地平已被证明可改善高血压患者的血管内皮功能,但S(-)-氨氯地平是否具有类似作用仍存在争议。这项研究比较了氨氯地平和S(-)-氨氯地平对高血压患者血管内皮功能的影响,并研究了细胞培养中的相关作用机制。方法在一项随机,交叉研究中,二十四例原发性高血压患者接受了氨氯地平和S(-)-氨氯地平治疗6周。确定了相关的血流介导的扩张(FMD),一氧化氮(NO)和内皮型一氧化氮合酶(eNOS)的水平。将人脐静脉内皮细胞(HUVEC)暴露于氨氯地平,S(-)-氨氯地平,eNOS抑制剂N w-硝基-L-精氨酸(L-NA)和蛋白激酶C(PKC)后,测量NO水平抑制剂Ro 31-8220。暴露于氨氯地平,S(-)-氨氯地平和Ro 31-8220后,测定eNOS中Ser1177和Thr495的磷酸化水平。结果氨氯地平和S(-)-氨氯地平治疗后,FMD,NO和eNOS水平显着提高。氨氯地平的水平均较高,尽管治疗间差异无统计学意义。氨氯地平和S(-)-氨氯地平显着增加了培养的HUVEC中的NO水平,但氨氯地平对NO水平的增加更为明显。蛋白质印迹分析表明,氨氯地平和Ro31-8220均可诱导eNOS中的Ser1177磷酸化并减弱Thr495磷酸化。 S(-)-氨氯地平没有类似作用。氨氯地平(但不是S(-)-氨氯地平)以时间依赖性方式降低PKC磷酸化。结论氨氯地平和S(-)-氨氯地平均可改善高血压患者的内皮功能。氨氯地平比S​​(-)-氨氯地平具有更大的血管内皮保护潜力。它通过PKC途径影响Ser 1177和Thr495处的eNOS磷酸化,进一步增强eNOS激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号